Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Further submissions announced for Visudyne

Sep. 13, 2001

Novartis, QLT seek approval for expanded use of Visudyne in E.U.

Sep. 12, 2001

Senju to develop ocular formulation of betotastine

Sep. 4, 2001

Alcon presents potential antiglaucoma 13-oxaprostaglandins at the ACS meeting

Aug. 31, 2001

Sumitomo claims compounds useful for neuroretinal degenerative diseases

Aug. 31, 2001

Medennium's SmartPlug receives E.U. clearance for treatment of dry eyes

Aug. 29, 2001

Visudyne approved for additional ocular conditions in the U.S.

Aug. 27, 2001

Cataracts improve with N-acetylcarnosine drops

Aug. 20, 2001

Use of beta-adrenoceptor antagonists for treating outer retina disorders described

Aug. 3, 2001

Series of adenosine antagonists reported by OSI in recent patent

July 31, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 9, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...